Shang, Boyu
Zhang, Tianyi
Liu, Chang
Yuan, Zonglin
Wang, Yao
Feng, Jing
Zhou, Yi
Funding for this research was provided by:
Natural Science Foundation of Heilongjiang Province of China (YQ2020H012)
the Research and Innovation Fund of the First Affiliated Hospital of Harbin Medical University (2020B12)
the China Postdoctoral Science Foundation (2020M670927)
the Heilongjiang Province Postdoctoral Fund (LBH-Z19171)
Article History
Received: 27 May 2025
Accepted: 28 July 2025
First Online: 3 September 2025
Declarations
:
: The study was approved by the Ethics Board of the First Affiliated Hospital of Harbin Medical University (No. 2024182) and complied with the Declaration of Helsinki guidelines. It was logged with the US Clinical Trial Registry (ID: NCT06565845) on August 21, 2024. Written informed consent was secured from all participants, with parental or legal guardian consent obtained for individuals under 16 years old.
: The authors declare no competing interests.